Bi-Directional Interactions between Glucose-Lowering Medications and Gut Microbiome in Patients with Type 2 Diabetes Mellitus: A Systematic Review

Background: Although common drugs for treating type 2 diabetes (T2D) are widely used, their therapeutic effects vary greatly. The interaction between the gut microbiome and glucose-lowering drugs is one of the main contributors to the variability in T2D progression and response to therapy. On the on...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ruolin, Shokri, Fereshteh, Rincon, Alejandro Lopez, Rivadeneira, Fernando, Medina-Gomez, Carolina, Ahmadizar, Fariba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454120/
https://www.ncbi.nlm.nih.gov/pubmed/37628624
http://dx.doi.org/10.3390/genes14081572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454120/
https://www.ncbi.nlm.nih.gov/pubmed/37628624
http://dx.doi.org/10.3390/genes14081572

Ejemplares similares